Source Natural

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE679C01027
NSEID:
BSEID: 531398

INR

138.90

0.25 (0.18%)

BSENSE

Dec 04

BSE+NSE Vol: 294

{
  "main_header": {
    "sid": 446660,
    "name": "Source Natural",
    "stock_name": "Source Natural",
    "full_name": "Source Natural Foods & Herbal Supplements Ltd",
    "name_url": "stocks-analysis/source-natural",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "138.90",
    "chg": 0.25,
    "chgp": "0.18%",
    "dir": 1,
    "prev_price": "138.65",
    "mcapval": "93.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531398,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE679C01027",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "294 ",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/source-natural-446660-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Source Natural falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-source-natural-fallingrising-3739621",
        "imagepath": "",
        "date": "2025-12-02 00:47:39",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Although the stock opened the day with a gap up of 4.01%, reaching an intraday high of ₹140, it ultimately succumbed to selling pressure, falling to an intraday low of ₹130.55 before settling lower. The weighted average price indicates that a greater volume of shares traded closer to the day’s low, signalling bearish sentiment among investors. Furthermore, Source Natural is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, underscoring a sustained downtrend in the stock’s price momentum.</p>\n<p>Investor participation has also waned, with delivery volumes on 28 November dropping by 64.1% compared to the five-day average, suggesting reduced conviction among shareholders. Despite th..."
      },
      {
        "title": "Source Natural Foods & Herbal Supplements: Analytical Perspective Shift Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/source-natural-foods-herbal-supplements-downgraded-to-sell-amid-mixed-technical-and-fundamental-signals-3730417",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SourceNaturalFo_mojoScore_3730417.png",
        "date": "2025-11-26 08:16:55",
        "description": "Source Natural Foods & Herbal Supplements has experienced a revision in its market assessment following a detailed analysis of its quality, valuation, financial trends, and technical indicators. Despite ongoing challenges in long-term returns and sector comparisons, recent quarterly financial results and evolving technical signals have influenced a nuanced shift in the company’s evaluation metrics."
      },
      {
        "title": "How has been the historical performance of Source Natural?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-source-natural-3729602",
        "imagepath": "",
        "date": "2025-11-25 22:54:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>Over the seven-year period ending March 2025, Source Natural’s net sales exhibited a robust upward trend, rising from ₹12.77 crores in March 2019 to ₹44.92 crores in March 2025. This represents a more than threefold increase, underscoring the company’s expanding market presence and sales capabilities. Total operating income followed a similar pattern, reflecting consistent growth in core business activities.</p>\n<p>Operating profit before depreciation, interest, and tax (PBDIT) also improved steadily, climbing from ₹1.56 crores in March 2019 to ₹5.23 crores in March 2025. However, operating profit margins have seen some compression in recent years, declining from a peak of over 18% in March 2023 to approximately 11.5% in March 2025. This margi..."
      },
      {
        "title": "Source Natural Foods & Herbal Supplements: Analytical Perspective Shift Amidst Market and Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/source-natural-foods-herbal-supplements-downgraded-to-strong-sell-amid-bearish-technicals-and-weak-returns-3719793",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SourceNaturalFo_mojoScore_3719793.png",
        "date": "2025-11-21 08:11:43",
        "description": "Source Natural Foods & Herbal Supplements has experienced a notable revision in its market assessment, reflecting changes across multiple evaluation parameters including quality, valuation, financial trends, and technical indicators. This article examines the factors influencing the recent shift in analytical perspective and what it signifies for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "How has been the historical performance of Source Natural?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-source-natural-3705053",
        "imagepath": "",
        "date": "2025-11-15 23:11:44",
        "description": "Answer:\nThe historical performance of Source Natural shows significant growth in net sales and profitability over the years, particularly from Mar'23 to Mar'25.\n\nBreakdown:\nSource Natural's net sales have increased from 19.77 Cr in Mar'23 to 44.92 Cr in Mar'25, reflecting a strong upward trend. Total operating income also rose from 19.77 Cr in Mar'23 to 44.92 Cr in Mar'25. However, the total expenditure has increased significantly, from 16.21 Cr in Mar'23 to 39.77 Cr in Mar'25, which has impacted the operating profit, which grew from 3.56 Cr in Mar'23 to 5.23 Cr in Mar'25. The profit before tax has shown a steady increase from 2.74 Cr in Mar'23 to 3.58 Cr in Mar'25, while profit after tax rose from 2.12 Cr in Mar'23 to 2.90 Cr in Mar'25. The earnings per share (EPS) improved from 3.29 in Mar'23 to 4.50 in Mar'25. On the balance sheet, total assets increased from 21.45 Cr in Mar'23 to 35.83 Cr in Mar'25, wit..."
      },
      {
        "title": "Source Natural Foods Q2 FY26: Strong Revenue Growth Masks Margin Erosion Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/source-natural-foods-q2-fy26-strong-revenue-growth-masks-margin-erosion-concerns-3715904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SourceNaturalFo_quaterlyResult_3715904.png",
        "date": "2025-11-15 09:28:52",
        "description": "Source Natural Foods & Herbal Supplements Ltd., a Bengaluru-based pharmaceutical company specialising in organic herbal formulations, reported a net profit of ₹0.70 crores in Q2 FY26, marking an 11.11% quarter-on-quarter increase but reflecting a 16.67% decline year-on-year. The micro-cap company, with a market capitalisation of ₹86.00 crores, delivered impressive revenue growth of 65.20% YoY to ₹16.95 crores, though this top-line expansion came at the cost of deteriorating profitability margins. Following the results, the stock traded at ₹148.00, reflecting a 5.71% single-day gain but remaining 43.08% below its 52-week high of ₹260.00."
      },
      {
        "title": "How has been the historical performance of Source Natural?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-source-natural-3703479",
        "imagepath": "",
        "date": "2025-11-15 00:01:33",
        "description": "Answer:\nThe historical performance of Source Natural shows a significant upward trend in net sales and profitability over the years.\n\nBreakdown:\nSource Natural's net sales have increased from 19.77 Cr in Mar'23 to 44.92 Cr in Mar'25, indicating strong growth. Total operating income followed a similar trend, rising to 44.92 Cr in Mar'25 from 19.77 Cr in Mar'23. The company's total expenditure also increased, reaching 39.77 Cr in Mar'25, but the operating profit (PBDIT) improved to 5.23 Cr in Mar'25 from 3.59 Cr in Mar'23, reflecting better cost management. Profit before tax showed a positive trend, increasing to 3.58 Cr in Mar'25 from 2.74 Cr in Mar'23, while profit after tax rose to 2.90 Cr in Mar'25 from 2.12 Cr in Mar'23. The earnings per share (EPS) also improved, reaching 4.5 in Mar'25 compared to 3.29 in Mar'23. On the balance sheet, total assets grew to 35.83 Cr in Mar'25 from 21.45 Cr in Mar'23, whil..."
      },
      {
        "title": "Is Source Natural overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-source-natural-overvalued-or-undervalued-3700131",
        "imagepath": "",
        "date": "2025-11-14 08:10:26",
        "description": "As of 13 November 2025, the valuation grade for Source Natural has moved from attractive to fair, indicating a reassessment of its market position. The company is currently fairly valued based on its financial metrics, with a PE ratio of 29.30, an EV to EBITDA of 16.59, and a PEG ratio of 0.46. These ratios suggest that while the company has growth potential, its current valuation aligns with its earnings and growth prospects.\n\nIn comparison to its peers, Source Natural's valuation appears reasonable. For instance, Sun Pharma has a significantly higher PE ratio of 36.15, while Cipla, considered attractive, has a PE of 22.65. The notable outperformance of Source Natural's PEG ratio at 0.46 compared to peers like Divi's Lab, which has a PEG of 1.99, further supports the conclusion that Source Natural is fairly valued. Additionally, the company's stock has underperformed against the Sensex over the past year, ..."
      },
      {
        "title": "How has been the historical performance of Source Natural?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-source-natural-3694074",
        "imagepath": "",
        "date": "2025-11-12 23:19:26",
        "description": "Answer:\nThe historical performance of Source Natural shows significant growth in net sales and profitability over the years, with the latest figures for March 2025 indicating net sales of 44.92 crore and a profit after tax of 2.90 crore.\n\nBreakdown:\nSource Natural has demonstrated a strong upward trend in net sales, increasing from 19.77 crore in March 2023 to 44.92 crore in March 2025. This growth is accompanied by a rise in operating profit, which reached 5.23 crore in March 2025, up from 3.59 crore in March 2023. The profit before tax also improved, standing at 3.58 crore in March 2025 compared to 2.74 crore in March 2023. Despite fluctuations in profit margins, the profit after tax margin remained relatively stable, with a slight increase to 6.46% in March 2025. On the balance sheet, total assets grew to 35.83 crore in March 2025, up from 21.45 crore in March 2023, while total liabilities also increased..."
      }
    ],
    "total": 207,
    "sid": "446660",
    "stock_news_url": "https://www.marketsmojo.com/news/source-natural-foods-herbal-supplements-446660"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2025",
      "details": "Newspaper Publication for Unaudited Financial results for the quarter and half year ended September 30 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "14-Nov-2025",
      "details": "Outcome of Board Meeting - Unaudited financial results of the company for the quarter and half year ended September 30 2025 along with Limited Review Report.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.",
      "datetime": "14-Nov-2025",
      "details": "Unaudited Financial results for the quarter and half year ended September 30 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Source Natural falling/rising?

2025-12-02 00:47:39

Recent Price Movement and Market Context

Although the stock opened the day with a gap up of 4.01%, reaching an intraday high of ₹140, it ultimately succumbed to selling pressure, falling to an intraday low of ₹130.55 before settling lower. The weighted average price indicates that a greater volume of shares traded closer to the day’s low, signalling bearish sentiment among investors. Furthermore, Source Natural is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, underscoring a sustained downtrend in the stock’s price momentum.

Investor participation has also waned, with delivery volumes on 28 November dropping by 64.1% compared to the five-day average, suggesting reduced conviction among shareholders. Despite th...

Source Natural Foods & Herbal Supplements: Analytical Perspective Shift Amid Mixed Financial and Technical Signals

2025-11-26 08:16:55

Source Natural Foods & Herbal Supplements has experienced a revision in its market assessment following a detailed analysis of its quality, valuation, financial trends, and technical indicators. Despite ongoing challenges in long-term returns and sector comparisons, recent quarterly financial results and evolving technical signals have influenced a nuanced shift in the company’s evaluation metrics.

How has been the historical performance of Source Natural?

2025-11-25 22:54:50

Revenue and Profitability Trends

Over the seven-year period ending March 2025, Source Natural’s net sales exhibited a robust upward trend, rising from ₹12.77 crores in March 2019 to ₹44.92 crores in March 2025. This represents a more than threefold increase, underscoring the company’s expanding market presence and sales capabilities. Total operating income followed a similar pattern, reflecting consistent growth in core business activities.

Operating profit before depreciation, interest, and tax (PBDIT) also improved steadily, climbing from ₹1.56 crores in March 2019 to ₹5.23 crores in March 2025. However, operating profit margins have seen some compression in recent years, declining from a peak of over 18% in March 2023 to approximately 11.5% in March 2025. This margi...

Source Natural Foods & Herbal Supplements: Analytical Perspective Shift Amidst Market and Financial Trends

2025-11-21 08:11:43

Source Natural Foods & Herbal Supplements has experienced a notable revision in its market assessment, reflecting changes across multiple evaluation parameters including quality, valuation, financial trends, and technical indicators. This article examines the factors influencing the recent shift in analytical perspective and what it signifies for investors navigating the Pharmaceuticals & Biotechnology sector.

How has been the historical performance of Source Natural?

2025-11-15 23:11:44

Answer: The historical performance of Source Natural shows significant growth in net sales and profitability over the years, particularly from Mar'23 to Mar'25. Breakdown: Source Natural's net sales have increased from 19.77 Cr in Mar'23 to 44.92 Cr in Mar'25, reflecting a strong upward trend. Total operating income also rose from 19.77 Cr in Mar'23 to 44.92 Cr in Mar'25. However, the total expenditure has increased significantly, from 16.21 Cr in Mar'23 to 39.77 Cr in Mar'25, which has impacted the operating profit, which grew from 3.56 Cr in Mar'23 to 5.23 Cr in Mar'25. The profit before tax has shown a steady increase from 2.74 Cr in Mar'23 to 3.58 Cr in Mar'25, while profit after tax rose from 2.12 Cr in Mar'23 to 2.90 Cr in Mar'25. The earnings per share (EPS) improved from 3.29 in Mar'23 to 4.50 in Mar'25. On the balance sheet, total assets increased from 21.45 Cr in Mar'23 to 35.83 Cr in Mar'25, wit...

Source Natural Foods Q2 FY26: Strong Revenue Growth Masks Margin Erosion Concerns

2025-11-15 09:28:52

Source Natural Foods & Herbal Supplements Ltd., a Bengaluru-based pharmaceutical company specialising in organic herbal formulations, reported a net profit of ₹0.70 crores in Q2 FY26, marking an 11.11% quarter-on-quarter increase but reflecting a 16.67% decline year-on-year. The micro-cap company, with a market capitalisation of ₹86.00 crores, delivered impressive revenue growth of 65.20% YoY to ₹16.95 crores, though this top-line expansion came at the cost of deteriorating profitability margins. Following the results, the stock traded at ₹148.00, reflecting a 5.71% single-day gain but remaining 43.08% below its 52-week high of ₹260.00.

How has been the historical performance of Source Natural?

2025-11-15 00:01:33

Answer: The historical performance of Source Natural shows a significant upward trend in net sales and profitability over the years. Breakdown: Source Natural's net sales have increased from 19.77 Cr in Mar'23 to 44.92 Cr in Mar'25, indicating strong growth. Total operating income followed a similar trend, rising to 44.92 Cr in Mar'25 from 19.77 Cr in Mar'23. The company's total expenditure also increased, reaching 39.77 Cr in Mar'25, but the operating profit (PBDIT) improved to 5.23 Cr in Mar'25 from 3.59 Cr in Mar'23, reflecting better cost management. Profit before tax showed a positive trend, increasing to 3.58 Cr in Mar'25 from 2.74 Cr in Mar'23, while profit after tax rose to 2.90 Cr in Mar'25 from 2.12 Cr in Mar'23. The earnings per share (EPS) also improved, reaching 4.5 in Mar'25 compared to 3.29 in Mar'23. On the balance sheet, total assets grew to 35.83 Cr in Mar'25 from 21.45 Cr in Mar'23, whil...

Is Source Natural overvalued or undervalued?

2025-11-14 08:10:26

As of 13 November 2025, the valuation grade for Source Natural has moved from attractive to fair, indicating a reassessment of its market position. The company is currently fairly valued based on its financial metrics, with a PE ratio of 29.30, an EV to EBITDA of 16.59, and a PEG ratio of 0.46. These ratios suggest that while the company has growth potential, its current valuation aligns with its earnings and growth prospects. In comparison to its peers, Source Natural's valuation appears reasonable. For instance, Sun Pharma has a significantly higher PE ratio of 36.15, while Cipla, considered attractive, has a PE of 22.65. The notable outperformance of Source Natural's PEG ratio at 0.46 compared to peers like Divi's Lab, which has a PEG of 1.99, further supports the conclusion that Source Natural is fairly valued. Additionally, the company's stock has underperformed against the Sensex over the past year, ...

How has been the historical performance of Source Natural?

2025-11-12 23:19:26

Answer: The historical performance of Source Natural shows significant growth in net sales and profitability over the years, with the latest figures for March 2025 indicating net sales of 44.92 crore and a profit after tax of 2.90 crore. Breakdown: Source Natural has demonstrated a strong upward trend in net sales, increasing from 19.77 crore in March 2023 to 44.92 crore in March 2025. This growth is accompanied by a rise in operating profit, which reached 5.23 crore in March 2025, up from 3.59 crore in March 2023. The profit before tax also improved, standing at 3.58 crore in March 2025 compared to 2.74 crore in March 2023. Despite fluctuations in profit margins, the profit after tax margin remained relatively stable, with a slight increase to 6.46% in March 2025. On the balance sheet, total assets grew to 35.83 crore in March 2025, up from 21.45 crore in March 2023, while total liabilities also increased...

View All News

Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication

15-Nov-2025 | Source : BSE

Newspaper Publication for Unaudited Financial results for the quarter and half year ended September 30 2025

Board Meeting Outcome for Outcome Of Board Meeting

14-Nov-2025 | Source : BSE

Outcome of Board Meeting - Unaudited financial results of the company for the quarter and half year ended September 30 2025 along with Limited Review Report.